FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2771916641> ?p ?o ?g. }

• W2771916641 endingPage "534" @default.
• W2771916641 startingPage "526" @default.
• W2771916641 abstract "Drug-resistant pathogen (DRP) risk stratification is important for choosing a treatment strategy for community-onset pneumonia. Evidence for benefits of non-antipseudomonal β-lactam plus macrolide combination therapy (BLM) on mortality is limited in patients at low DRP risk. Risk factors for mortality remain to be clarified.Post hoc analysis using a prospective multicentre study cohort of community-onset pneumonia was performed to assess 30-day differences in mortality between non-antipseudomonal β-lactam monotherapy (BL) and BLM groups. Logistic regression analysis was performed to assess the therapeutic effect and risk factors for mortality in patients at low DRP risk.In total, 594 patients with community-onset pneumonia at low DRP risk (369 BL and 225 BLM) were analysed. The 30-day mortality in BL and BLM was 13.8% and 1.8%, respectively (P < 0.001). Multivariate analysis showed that BLM reduced the 30-day mortality (adjusted odds ratio: 0.28, 95% CI: 0.09-0.87) compared with BL. Independent prognostic factors for 30-day mortality included arterial partial pressure of carbon dioxide (PaCO2 ) > 50 mm Hg, white blood cell count < 4000/mm3 , non-ambulatory status, albumin < 3.0 g/dL, haematocrit < 30%, age ≥ 80 years, respiratory rate > 25/min and body temperature < 36°C.In patients with community-onset pneumonia at low DRP risk, BLM treatment reduced 30-day mortality compared with BL. Independent risk factors for mortality are potential confounding factors when assessing antibiotic effects in randomized clinical trials." @default.
• W2771916641 created "2017-12-22" @default.
• W2771916641 creator A5001024350 @default.
• W2771916641 creator A5028104320 @default.
• W2771916641 creator A5038162416 @default.
• W2771916641 creator A5045508144 @default.
• W2771916641 creator A5053378428 @default.
• W2771916641 creator A5054408940 @default.
• W2771916641 creator A5056106763 @default.
• W2771916641 creator A5060250789 @default.
• W2771916641 creator A5068641154 @default.
• W2771916641 creator A5087279007 @default.
• W2771916641 date "2017-12-14" @default.
• W2771916641 modified "2023-09-28" @default.
• W2771916641 title "Mortality in patients with community-onset pneumonia at low risk of drug-resistant pathogens: Impact of β-lactam plus macrolide combination therapy" @default.
• W2771916641 cites W1545891906 @default.
• W2771916641 cites W1693418437 @default.
• W2771916641 cites W1898928487 @default.
• W2771916641 cites W1977040652 @default.
• W2771916641 cites W1977624143 @default.
• W2771916641 cites W2007686494 @default.
• W2771916641 cites W2014847700 @default.
• W2771916641 cites W2017165324 @default.
• W2771916641 cites W2042031141 @default.
• W2771916641 cites W2062871641 @default.
• W2771916641 cites W2096667163 @default.
• W2771916641 cites W2100670008 @default.
• W2771916641 cites W2100998220 @default.
• W2771916641 cites W2102361557 @default.
• W2771916641 cites W2104661713 @default.
• W2771916641 cites W2111603601 @default.
• W2771916641 cites W2116393998 @default.
• W2771916641 cites W2116585051 @default.
• W2771916641 cites W2117036615 @default.
• W2771916641 cites W2123324969 @default.
• W2771916641 cites W2130386629 @default.
• W2771916641 cites W2133008785 @default.
• W2771916641 cites W2133979383 @default.
• W2771916641 cites W2142191165 @default.
• W2771916641 cites W2142413409 @default.
• W2771916641 cites W2146733517 @default.
• W2771916641 cites W2150772812 @default.
• W2771916641 cites W2150777153 @default.
• W2771916641 cites W2163052162 @default.
• W2771916641 cites W2166855608 @default.
• W2771916641 cites W2171284117 @default.
• W2771916641 cites W2273028993 @default.
• W2771916641 cites W2286383228 @default.
• W2771916641 cites W2298547323 @default.
• W2771916641 cites W2320270386 @default.
• W2771916641 cites W2460157309 @default.
• W2771916641 cites W2473016454 @default.
• W2771916641 cites W2591697569 @default.
• W2771916641 cites W2744591965 @default.
• W2771916641 doi "https://doi.org/10.1111/resp.13232" @default.
• W2771916641 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29239493" @default.
• W2771916641 hasPublicationYear "2017" @default.
• W2771916641 type Work @default.
• W2771916641 sameAs 2771916641 @default.
• W2771916641 citedByCount "18" @default.
• W2771916641 countsByYear W27719166412017 @default.
• W2771916641 countsByYear W27719166412018 @default.
• W2771916641 countsByYear W27719166412019 @default.
• W2771916641 countsByYear W27719166412020 @default.
• W2771916641 countsByYear W27719166412021 @default.
• W2771916641 countsByYear W27719166412022 @default.
• W2771916641 countsByYear W27719166412023 @default.
• W2771916641 crossrefType "journal-article" @default.
• W2771916641 hasAuthorship W2771916641A5001024350 @default.
• W2771916641 hasAuthorship W2771916641A5028104320 @default.
• W2771916641 hasAuthorship W2771916641A5038162416 @default.
• W2771916641 hasAuthorship W2771916641A5045508144 @default.
• W2771916641 hasAuthorship W2771916641A5053378428 @default.
• W2771916641 hasAuthorship W2771916641A5054408940 @default.
• W2771916641 hasAuthorship W2771916641A5056106763 @default.
• W2771916641 hasAuthorship W2771916641A5060250789 @default.
• W2771916641 hasAuthorship W2771916641A5068641154 @default.
• W2771916641 hasAuthorship W2771916641A5087279007 @default.
• W2771916641 hasBestOaLocation W27719166411 @default.
• W2771916641 hasConcept C126322002 @default.
• W2771916641 hasConcept C156957248 @default.
• W2771916641 hasConcept C179755657 @default.
• W2771916641 hasConcept C188816634 @default.
• W2771916641 hasConcept C2776102371 @default.
• W2771916641 hasConcept C2777914695 @default.
• W2771916641 hasConcept C71924100 @default.
• W2771916641 hasConceptScore W2771916641C126322002 @default.
• W2771916641 hasConceptScore W2771916641C156957248 @default.
• W2771916641 hasConceptScore W2771916641C179755657 @default.
• W2771916641 hasConceptScore W2771916641C188816634 @default.
• W2771916641 hasConceptScore W2771916641C2776102371 @default.
• W2771916641 hasConceptScore W2771916641C2777914695 @default.
• W2771916641 hasConceptScore W2771916641C71924100 @default.
• W2771916641 hasFunder F4320324312 @default.
• W2771916641 hasIssue "5" @default.
• W2771916641 hasLocation W27719166411 @default.
• W2771916641 hasLocation W27719166412 @default.
• W2771916641 hasOpenAccess W2771916641 @default.

• next